Reference
- Carreras, E., Bertz, H., Arcese, W., et al. (1998) "Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of European Group fo Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party", Blood, 92, 3599 — 3604.
- Boyer, T.D. (2003) "Transjugular intrahepatic portosystemic shunt: current status", Gastroenterology, 124, 1700–1710.
- Zenz, T., Rossle, M., Bertz, H., Siegerstetter, V., Ochs, A. and Finke, J. (2001) "Severe veno-occlusive disease after allogeneic bone marrow transplantation: role of transjugular intrahepatic portosys-temic shunt (TIPS)", Liver, 21, 31–36.
- Bearman, S.I. (2001) "Avoiding hepatic veno-occlusive disease: what do we know and where are we going", Bone Marrow Transpl., 27, 1113–1120.
- Azoulay, D., Castaing, D., Lemoine, A., et al. (2001) "Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation", Bone Marrow Transplant., 25, 987–992.
- McDonald, GB., Shulman, H.M., Wolford, J.L. and Spencer, G.D. (1987) "Liver disease after human marrow transplantation", Semin. Liver Dis., 7, 210–229.
- Bearman, S.I., Lee, J.L., Baron, A.E. and McDonald, G.B. (1997) "Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients", Blood, 89, 1501–1506.
- Richardson, P. and Guinan, E. (1999) "The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches", Br. J. Haematol., 107, 485 — 493.
- Berk, P.D., Popper, H., Krueger, G.R., Dekter, J., Herzig, G. and Graw, R.G. Jr. (1979) "Veno-occlusive of the liver after allogeneic bone marrow transplantation: possible association with graft versus host disease", Ann. Int. Med., 90, 158–164.
- Sebagh, M., Debette, M., Samuel, D., et al. (1999) "'Silent' presentation of veno-occlusive disease after liver transplantation as part of a process of cellular rejection with endothelial predilection", Hepatology, 30, 1144–1150.